Amarin Corp Plc (AMRN)

[HDGabor]

m- (&concapk & MNBioMike)

we will start seeing 4Q19 Form 10 disclosures?

I am not sure what about your question but the next Form 10 will be "February (Week 9 … TBA): Q4 & FY 2019 (10-K and CC)"

concapk: I believe you might be low concerning Canadian 2020 sales.... they are notorious for selling product (drugs) to the US market by simply shipping thru US mail

The net result is worse … I do not think the higher licencising revenue from Canada will off-set the lost revenue in the US … will not be new / additional revenue.
It could increase the revenue IF this sales will be to US citizen who does not buy (for any reason) in the US … will not be to US citizen who replace higher cost US Vascepa with lower cost Canadian Vascepa.

MNBioMike: Need to add Evap results as well.

Estimated Study Completion Date?: Q2 2020 (end of June 2020). I think the data will be reserved for / presented during AHA 2020 (November). However I do not see this study as a material / relevant for V commercial success. It could give (one) explanation about the MoA … but I do not expect a material effect on sales.

Best,
G